Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Francesca Bruce

Francesca Bruce has been writing news and analysis about all things affecting the pharmaceutical industry since 2008. She has paid special attention to policy and regulatory developments but particularly likes to write about market access and how medicines may  - or may not  -  make it to patients. She generally writes about Europe, but really enjoys uncovering news from further corners of the globe, especially Latin America and the Middle East.
Advertisement
Set Alert for Articles By Francesca Bruce

Latest From Francesca Bruce

Venezuela Shuns ‘Multinational Pharmaceutical Cartel’ And Turns To Pan American Health Organization

Venezuela has accused the pharmaceutical industry of holding up medicines supplies and says it will acquire them instead through the Pan American Health Organization.

South America Venezuela

UK Industry Raises Conflict of Interest Concerns Over NICE’s PRIMA Service

PRIMA, the new service the National Institute for Health and Care Excellence offers to review economic models, must not be affected by confidentiality and conflict of interest issues, warns UK the pharmaceutical industry group, ABPI.

Europe United Kingdom

Argentina Considers Creating National HTA Body

Argentina could be on the way to creating a national health technology appraisal organization.

South America Argentina

Takeda Gives UK’s NICE Economic Model Review Service Thumbs Up

A new service provided by UK HTA body NICE for evaluating economic models that will be reviewed by health technology appraisal bodies has been a success, according to Takeda.

Europe United Kingdom

Increased Fees For Pharma Imminent In Australia

From July 1, pharmaceutical companies will pay higher fees to Australia’s Therapeutic Goods Administration.

Asia Pacific Australia

Court Ruling On Pfizer Price Hikes Could Delay Other Investigations, Warns UK Competition Authority

Ongoing Investigations into drug price increases could be at risk following a tribunal ruling in the UK phenytoin sodium case, according to the Competition and Markets Authority, which is considering an appeal against the judgment.

Europe United Kingdom
See All
Advertisement
UsernamePublicRestriction

Register